Gaining a deeper understanding of the role and properties of irisin could pave the way for new therapeutic strategies for bone diseases, such as osteoporosis, while also identifying a new biomarker of the muscular state to facilitate diagnosis and consequently the timely initiation of therapy in patients with sarcopenia or muscle diseases. This evidence concerns the gene FNDC5 and osteoporosis.